arrow
J

Jonathan Rennhack

loyola university chicago stritch school of medicine
H指数:19
被引数:1,161

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MYC primes a paralog synthetic lethality involving the mitochondrial translocase subunits TIMM17A and TIMM17B and N-Acetylaspartate

MYC通过线粒体转位酶亚基TIMM17A和TIMM17B以及N-乙酰天冬氨酸触发旁系同源合成致死作用

2026-11-060
OA
Author Correction: CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer

作者更正:CREB5 促进致瘤性并上调可成药性细胞表面模态在基底样乳腺癌中

2025-11-200
OAAI
CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer

CREB5促进基底样乳腺癌的致瘤性,并上调可靶向的细胞表面模式识别分子。

2025-08-060
OAAI
CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies

CREB5重新编程FOXA1核相互作用以促进对雄激素受体靶向疗法的抗性

2022-05-1213
OAAI
SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization
2021-07-0125
OAAI
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers
2019-10-0170
OAAI
Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted Therapy

减少全球H3K27me3增强HER2/ErbB2靶向治疗

2019-10-0131
OAAI